No inflammatory breast cancer
Participant with inflammatory breast cancer.
Inflammatory breast cancer
Diagnosis of inflammatory breast cancer
FOR ALL PHASES (Ib AND II): Inflammatory breast cancer
Inflammatory breast cancer
Diagnosis of inflammatory breast carcinoma
Inflammatory (T4d) breast cancer
Documentation of inflammatory breast cancer
Inflammatory breast cancer or patients with rapidly progressing metastatic breast cancer
Diagnosis of inflammatory breast cancer
Have no inflammatory breast cancers
Patients with bilateral or inflammatory breast cancer
Inflammatory breast cancer
Inflammatory breast cancer
Patients with inflammatory breast carcinoma
Patients with inflammatory breast cancer
Bilateral or inflammatory breast cancer
Inflammatory breast cancer
Inflammatory breast cancer or tumor with deep adherence or cutaneous invasion
Diagnosis of inflammatory breast cancer
Patients must have the clinical diagnosis of inflammatory breast cancer
Patients with inflammatory breast cancer
Subject has inflammatory breast cancer
Inflammatory breast cancer
Patients must not have inflammatory breast cancer and must not have metastatic disease
Active inflammatory breast cancer
Patient with inflammatory breast cancer at screening
Subject has inflammatory breast cancer
Inflammatory breast cancer or tumor with deep adherence or cutaneous invasion;
Subjects with Inflammatory breast cancer.
Inflammatory breast cancer
Patient with inflammatory breast cancer at screening .
Patients who currently have inflammatory breast cancer at screening.
Have inflammatory breast cancer
Inflammatory/inoperable breast cancer.
Patients must not have inflammatory breast cancer (T4d) and must not have metastatic breast cancer (stage IV disease)
Male and female participants with locally advanced, inflammatory, or early-stage, unilateral, and histologically confirmed invasive breast cancer. Participants with inflammatory breast cancer must be able to have a core needle biopsy
Evidence of inflammatory breast cancer
Inflammatory breast cancer.
Inflammatory breast cancer
Patient with inflammatory breast cancer
Inflammatory or metaplastic breast cancer
Subjects with inflammatory breast cancer
Subjects with a diagnosis of non-inflammatory breast cancer or carcinoma in situ
Subjects with Inflammatory breast cancer.
Patients with inflammatory breast cancer are eligible for the escalation phase of the mastectomy cohort
Inflammatory breast cancer patients are ineligible, except in the escalation phase of the mastectomy cohort
Inflammatory breast malignancy
Participants with inflammatory breast cancer or multi-centric disease
Participants with locally advanced breast cancer such as inflammatory breast cancer or cancer grossly involving skin
Inflammatory breast cancer
Patients with stage T1 or greater (T1-T4), nodal involvement (N0-N3), without metastasis (M0) invasive breast cancer, including patients with inflammatory breast cancer
Any patient with confirmed metastatic disease. Patients with inflammatory breast cancer.
